The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer

Abstract In this study, we determined the efficacy of the cell death biomarker cytokeratin 18 for diagnosing biliary tract cancer (BTC). We recruited 36 patients with BTC (Malignant group) and 45 patients with benign biliary tract disease (Benign group) for this study. We used M30 and M65 as cell de...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mitsuru Sugimoto, Kazumichi Abe, Manabu Hayashi, Tadayuki Takagi, Rei Suzuki, Naoki Konno, Hiroyuki Asama, Yuki Sato, Hiroki Irie, Ko Watanabe, Jun Nakamura, Hitomi Kikuchi, Yuichi Waragai, Mika Takasumi, Minami Hashimoto, Takuto Hikichi, Yoshihiro Nozawa, Hiromasa Ohira
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2018
Materias:	Cell Death Biomarkers Biliary Tract Cancer (BTC) Biliary Cytology Malignant Group Benign Biliary Tract Disease Medicine R Science Q
Acceso en línea:	https://doaj.org/article/3a2bfe63fe304f33a6de52b0dae27cfd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer

Ejemplares similares